论文信息 - Reducing chemotherapy use in clinically high-risk, genomically low-risk pN0 and pN1 early breast cancer patients: five-year data from the prospective, randomised phase 3 West German Study Group (WSG) PlanB trial - 字舞流文

Reducing chemotherapy use in clinically high-risk, genomically low-risk pN0 and pN1 early breast cancer patients: five-year data from the prospective, randomised phase 3 West German Study Group (WSG) PlanB trial

S. Shak | N. Harbeck | O. Gluz | S. Kuemmel | C. Liedtke | T. Reimer | H. Kreipe | R. Kates | C. Chao | U. Nitz | R. Wuerstlein | M. Clemens | M. Christgen | P. Krabisch | B. Aktas | B. Nuding | W. Malter | D. Augustin | F. Lorenz-Salehi | M. Just | A. Stefek